AT-130 (Standard)

Overview

AT-130 (Standard) is the analytical standard of AT-130 ( HY-100028 ). This product is intended for research and analytical applications. AT-130 , a phenylpropenamide derivative, is a potent hepatitis B virus ( HBV ) replication non-nucleoside inhibitor. AT-130 inhibits the viral DNA synthesis with an EC50 of 0.13 μM. AT-130 inhibits both wt and mutant HBVs. AT-130 has anti-HBV activity in hepatoma cells.

Application

Products | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Others | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Signaling Pathways > HBV | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > DNA/RNA Synthesis

Product Information

• Catalog No.: HY-100028R
• CAS No.: 211364-06-6
• Molecular Formula: C22H22BrN3O5
• Molecular Weight: 488.33
• Purity: 95%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source